Modelling of the blood–brain barrier in drug discovery and development (original) (raw)

• Ballabh, P., Braun, A. & Nedergaard M. The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1–13 (2004).
  CAS PubMed Google Scholar
• Huber, J. D., Egleton R. D. & Davis, T. P. Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier. Trends Neurosci. 12, 719–725 (2001).
  Google Scholar
• Bradbury, M. The concept of a blood–brain barrier. (Wiley, New York, 1979).
  Google Scholar
• Pardridge, W. M. Peptide drug delivery to the brain. (Raven Press, New York,1991).
  Google Scholar
• Pardridge, W. M. et al. Comparison of in vitro and in vivo models of drug transcytosis through the blood–brain barrier. J. Pharmacol. Exp. Ther. 253, 884–891 (1990).
  CAS PubMed Google Scholar
• Ghersi-Egea, J. F., Leninger-Muller, B., Suleman, G., Siest, G. & Minn, A. Localisation of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J. Neurochem. 62, 1089–1096 (1994).
  CAS PubMed Google Scholar
• El-Bacha, R. S. & Minn, A. Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain. Cell. Mol. Biol. 45, 15–23 (1999).
  CAS PubMed Google Scholar
• Fenstermacher, J. D. et al. Relationship of capillary density to glucose utilization and blood flow in white and grey matter of the rat brain. Microvasc. Res. 29, 219–220 (1985).
  Google Scholar
• Sakurada, O. et al. Measurement of local cerebral blood flow with iodo[ 14C]antipyrine. Am. J. Physiol. 234, H59–H66 (1978).
  CAS PubMed Google Scholar
• Craigie, E. H. On the relative vascularity of various parts of the central nervous system of the albino rat. J. Comp. Neurol. 31, 429–464 (1920).
  Google Scholar
• Jones, E. G. On the mode of entry of blood vessels into the cerebral cortex. J. Anat. 106, 507–520 (1970).
  CAS PubMed PubMed Central Google Scholar
• Maynard, E. A. Electron microscopy of the vascular bed of rat cerebral cortex. Am. J. Anat. 100, 409–433 (1957).
  CAS PubMed Google Scholar
• Simard, M., Arcuino, G., Takano, T., Liu, Q. S. & Nedergaard, M. Signalling at the gliovascular interface. J. Neurosci. 23, 9254–9262 (2003).
  CAS PubMed Google Scholar
• Pellerin, L. & Magistretti, P. J. Food for thought: challenging the dogmas. J. Cereb. Blood Flow Metab. 23, 1282–1286 (2003).
  PubMed Google Scholar
• Newman, E. A. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci. 26, 536–542 (2003).
  CAS PubMed Google Scholar
• Edvinsson, L. & Hamel, E. Cerebral Blood Flow and Metabolism (eds Edvinsson, L. & Krause, D. N.) 43–67 (Lippincott, Williams and Wilkins, Philadelphia, 2002).
  Google Scholar
• Wolburg, H. et al. Modulation of tight junction structure in blood–brain barrier endothelial cells: Effects of tissue culture, second messager and cocultured astrocytes. J. Cell Sci. 107, 1347–1357 (1994).
  CAS PubMed Google Scholar
• Boado, R. J., Wang, L. & Pardridge, W. M. Enhanced expression of the blood–brain barrier GLUT1 glucose transporter gene by brain-derived factors. Brain Res. Mol. Brain Res. 22, 259–267 (1994).
  CAS PubMed Google Scholar
• Raub, T. J. Signal transduction and glial cell modulation of cultured brain microvessel endothelial cell tight junctions. Am. J. Physiol. 271, C495–C503 (1996).
  CAS PubMed Google Scholar
• Rist, R. J. et al. F-actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: Effects of cyclic AMP and astrocytic factors. Brain Res. 768, 10–18 (1997).
  CAS PubMed Google Scholar
• Roux, F. et al. Regulation of γ-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cell line. J. Cell Physiol. 159, 101–113 (1994).
  CAS PubMed Google Scholar
• Dehouck, B., Dehouck, M. P., Fruchard, J. C. & Cecchelli, R. Upregulation of the low density lipoprotein receptor at the blood–brain barrier:Intercommunications between brain capillary endothelial cells and astrocytes. J. Cell. Biol. 126, 465–473 (1994).
  CAS PubMed Google Scholar
• DeBault, L. E. & Cancilla, P. A. γ-Glutamyltranspeptidase in isolated brain endothelial cells: induction by glial cells in vitro. Science 207, 653–655 (1980).
  CAS PubMed Google Scholar
• Hayashi, Y. et al. Induction of various blood–brain barrier properties in non-neuronal endothelial cells by close apposition to co-cultured astrocytes. Glia 19, 13–26 (1997).
  CAS PubMed Google Scholar
• Sobue, K. et al. Induction of blood–brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci. Res. 35, 155–164 (1999).
  CAS PubMed Google Scholar
• Abbott, N. J. Astrocyte-endothelial interactions and blood–brain barrier permeability. J. Anat. 200, 629–638 (2002).
  CAS PubMed PubMed Central Google Scholar
• Haseloff, R. F., Blasig, I. E., Bauer H. C. & Bauer, H. In search of the astrocytic factor(s) modulating blood–brain barrier functions in brain capillary endothelial cells in vitro. Cell. Mol. Neurobiol. 25, 25–39 (2005).
  CAS PubMed Google Scholar
• Pardridge, W. M., Triguero, D., Buciak, J. & Yang, J. Evaluation of cationized rat albumin as a potential blood–brain barrier drug transport vector. Exp. Neurol. 255, 893–899 (1990).
  CAS Google Scholar
• Pardridge, W. M. Drug and gene targeting to the brain with molecular Trojan horses. Nature Rev. Drug Discov. 1, 131–139 (2002).
  CAS Google Scholar
• Scherrmann, J. M. Drug delivery to brain via the blood–brain barrier. Vascul Pharmacol. 38, 349–354 (2002).
  CAS PubMed Google Scholar
• Demeule, M. et al. High transcytosis of melanotransferrin (P97) across the blood–brain barrier. J. Neurochem. 83, 924–933 (2002).
  CAS PubMed Google Scholar
• Abulrob, A., Sprong, H., Van Bergen en Henegouwen, P. & Stanimirovic, D. The blood–brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. J. Neurochem. 95, 1201–1214 (2005).
  CAS PubMed Google Scholar
• Benchenane, K. et al. Tissue-type plasminogen activator crosses the intact blood–brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation 111, 2241–2249 (2005).
  CAS PubMed Google Scholar
• Benchenane, K. et al. Oxygen glucose deprivation switches the transport of tPA across the blood–brain barrier from an LRP-dependent to an increased LRP-independent process. Stroke 36, 1065–1070 (2005).
  PubMed Google Scholar
• Lopez-Atalaya, J. P. et al. Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood–brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects. Stroke 38, 1036–1043 (2007).
  CAS PubMed Google Scholar
• Brillault, J., Berezowski, V., Cecchelli, R. & Dehouck, M. P. Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the blood–brain barrier during ischaemia. J. Neurochem. 83, 807–817 (2002).
  CAS PubMed Google Scholar
• Hirano, A., Kawanami, T. & Llena J. F. Electron microscopy of the blood–brain barrier in disease. Microsc. Res. Tech. 27, 543–556 (1994).
  CAS PubMed Google Scholar
• Joó, F. Increased production of coated vesicles in the brain capillaries during enhanced permeability of the blood–brain barrier. Br. J. Exp. Pathol. 52, 646–649 (1971).
  PubMed PubMed Central Google Scholar
• Povlishock, J. T., Becker, D. P., Sullivan, H. G. & Miller, J. D. Vascular permeability alterations to horseradish peroxidase in experimental brain injury. Brain Res. 153, 223–239 (1978).
  CAS PubMed Google Scholar
• Ford, J. M. Modulators of multidrug resistance. Preclinical studies. Hematol. Oncol. Clin. North Am. 9, 337–361 (1995).
  CAS PubMed Google Scholar
• Schinkel, A. H. et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs. Cell 77, 491–502 (1994).
  CAS PubMed Google Scholar
• Schinkel, A. H. The physiological function of drug transporting P-glycoproteins. Semin. Cancer Biol. 8, 161–170 (1997).
  CAS PubMed Google Scholar
• Schinkel, A. H. & Jonker, J. W. Mammalian drug efflux transporters of the ATP-binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55, 3–29 (2003).
  CAS PubMed Google Scholar
• Kruh, G. D., Guo, Y., Hopper-Borge, E., Belinsky, M. G. & Chen, Z. S. ABCC10, ABCC11 and ABCC12. Pflugers Arch. 26 Jul 2006 [Epub ahead of print].
  Google Scholar
• Zhang, Y. Schuetz, J. D., Elmquist, W. F. & Miller, D. W. Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. JPET 311, 449–455 (2004).
  CAS Google Scholar
• Soontornmalai, A., Vlaming, M. L. & Fritschy, J. M. Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood–brain barrier. Neurosci. 138, 159–169 (2006).
  CAS Google Scholar
• Sugarawa, I., Hamada, H., Tsuruo, T. & Mori, S. Specialized localization of P-glycoprotein recognized by MRK16 monoclonal antibody in endothelial cells of the brain and the spinal cord. Jpn. J. Cancer Res. 81, 727–730 (1990).
  Google Scholar
• Tsuji, A. et al. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. 51, 1427–1437 (1992).
  CAS PubMed Google Scholar
• Stewart, P. A., Beliveau, R. & Rogers, K. A. Cellular localization of P-glycoprotein in brain versus gonadal capillaries. J. Histochem. Cytochem. 44, 679–685 (1996).
  CAS PubMed Google Scholar
• Beaulieu, E., Demeule, M., Ghitescu, L. & Béliveau, R. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem. J. 326, 539–544 (1997).
  CAS PubMed PubMed Central Google Scholar
• Scherrmann, J. M. Expression and function of multidrug resistance transporters at the blood–brain barriers. Expert Opin Drug Metab. Toxicol. 1, 233–246 (2005).
  CAS PubMed Google Scholar
• Dallas, S., Miller, D. S. & Bendayan, R. Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol Rev. 58, 140–161 (2006).
  CAS PubMed Google Scholar
• Seetharaman, S., Barrand, M. A., Maskell, L. & Scheper, R. J. Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates. J. Neurochem. 70, 1151–1159 (1998).
  CAS PubMed Google Scholar
• Gutmann, H., Fricker, G., Drewe, J., Toeroek, M. & Miller, D. S. Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol. Pharmacol. 56, 383–389 (1999).
  CAS PubMed Google Scholar
• Sugiyama, Y., Kusuhara, H. & Suzuki, H. Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood-brain and blood-cerebrospinal fluid barriers: importance in the drug delivery to the brain. J. Control Release 62, 179–186 (1999).
  CAS PubMed Google Scholar
• Fenart, L. et al. Inhibition of P-glycoprotein: rapid assessment of its implication in blood–brain barrier integrity and drug transport to the brain by an in vitro model of the blood–brain barrier. Pharm. Res. 15, 993–1000 (1998).
  CAS PubMed Google Scholar
• Berezowski, V., Landry, C., Dehouck, M. P., Cecchelli, R. & Fenart, L. Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood–brain barrier. Brain Res. 1018, 1–9 (2004).
  CAS PubMed Google Scholar
• Borst, P., Evers, R., Kool, M. & Wijnholds, J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl Cancer Inst. 92, 1295–1302 (2000).
  CAS PubMed Google Scholar
• Loscher, W. & Potschka, H. Blood–brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx. 2, 86–98 (2005).
  PubMed PubMed Central Google Scholar
• Evers, R. et al. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J. Clin. Invest. 97, 1211–1218 (1996).
  CAS PubMed PubMed Central Google Scholar
• Kusuhara, H. & Sugiyama, Y. Active efflux across the blood–brain barrier:carrier family. NeuroRx. 2, 73–85 (2005).
  PubMed PubMed Central Google Scholar
• Eisenblatter, T., Huwel, S. & Galla, H. J. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood–brain barrier. Brain Res. 971, 221–231 (2003).
  CAS PubMed Google Scholar
• Abbott, N. J. Prediction of blood–brain barrier permeation in drug discovery from in vivo, in vitro and in silico models. Drug Discov. Today: Technol. 1, 407–416 (2004).
  CAS Google Scholar
• Reichel, A. The role of blood–brain barrier studies in the pharmaceutical industry. Curr. Drug Metab. 7, 183–203 (2006).
  CAS PubMed Google Scholar
• Joó, F. The blood–brain barrier in vitro: ten years of research on microvessels isolated from the brain. Neurochem. Int. 7, 1–25 (1985).
  PubMed Google Scholar
• Muruganandam, A., Herx, L. M., Monette, R., Durkin, J. P. & Stanimirovic, D. B. Development of immortalized cerebromicrovascular endothelial cell line as an in vitro model of the human blood–brain barrier. FASEB J. 11, 1187–1197 (1997).
  CAS PubMed Google Scholar
• Weksler, B. B. et al. Blood–brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19, 1872–1874 (2005).
  CAS PubMed Google Scholar
• Kannan, R., Chakrabarti, R., Tang, D., Kim, K. J. & Kaplowitz, N. GSH transport in human cerebrovascular endothelial cells and human astrocytes: Evidence for luminal localization of Na+-dependent GSH transport in HCEC. Brain Res. 852, 374–382 (2000).
  CAS PubMed Google Scholar
• Demeuse, P. et al. Compartmentalized coculture of rat brain endothelial cells and astrocytes: a syngenic model to study the blood–brain barrier. J. Neurosci. Methods 121, 21–31 (2002).
  PubMed Google Scholar
• Perrière, N. et al. A functional in vitro model of rat blood–brain barrier for molecular analysis of efflux transporters. Brain Res. 1150, 1–13 (2007).
  PubMed Google Scholar
• Coisne, C., et al. Development and characterization of a mouse syngenic in vitro blood–brain barrier model: A new tool to examine inflammatory events on cerebral endothelium. Lab Invest. 85, 735–746 (2005).
  Google Scholar
• Méresse, S. et al. Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture. J. Neurochem. 53, 1363–1371 (1989).
  PubMed Google Scholar
• Dehouck, M. P., Méresse, S., Delorme, P., Fruchard, J. C. & Cecchelli, R. An easier, reproducible and mass production method to study the blood–brain barrier in vitro. J. Neurochem. 54, 1798–1801 (1990). One of the earliest papers describing a reproducible method for developing a BBB co-culture model with brain endothelial and glial cells that could be used in the pharmaceutical industry. Besides its use as BBB permeability and transport screen, the model has also been used in mechanistic studies in physiological and pathological conditions.
  CAS PubMed Google Scholar
• Cecchelli, R. et al. In vitro model for evaluating drug transport across the blood–brain barrier. Adv. Drug Deliv. Rev. 36, 165–178 (1999).
  CAS PubMed Google Scholar
• Rubin, L. L. et al. A cell culture model of the blood–brain barrier. J. Cell Biol. 115, 1725–1735 (1991).
  CAS PubMed Google Scholar
• O´Donnell, M. E., Martinez, A. & Sun, D. Cerebral microvascular endothelial cell NA-K-Cl co-transport: Regulation by astrocyte-conditioned medium. Am. J. Physiol. 268, C747–C754 (1995).
  Google Scholar
• Hurst, R. D. & Fritz, I. B Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood–brain barrier, J. Cell Physiol. 167, 81–88 (1996).
  CAS PubMed Google Scholar
• Boveri, M. et al. Induction of blood–brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line. Glia 51, 187–198 (2005).
  PubMed Google Scholar
• Hoheisel, D. et al. Hydrocortisone reinforces the blood–brain barrier properties in a serum free cell culture system. Biochem. Biophys. Res. Commun. 247, 312–315 (1998).
  CAS PubMed Google Scholar
• Franke, H., Galla, H. J. & Beuckmann, C. T. An improved low-permeability _in vitro_-model of the blood–brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res. 818, 65–71, (1999).
  CAS PubMed Google Scholar
• Zhang, Y. et al. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood–brain barrier permeability. Drug Metab. Dispos. 34, 1935–1943 (2006).
  CAS PubMed Google Scholar
• Arthur, F. E., Shivers, R. R. & Bowman, P. D. Astrocyte-mediated induction of tight junctions in brain capillary endothelium: an efficient in vitro model. Dev. Brain Res. 36, 155–159 (1987).
  Google Scholar
• Descamps, L., Coisne, C., Dehouck, B., Cecchelli, R. & Torpier, G. Protective effect of glial cells against lipopolysaccharide-mediated blood–brain barrier injury. Glia 42, 46–58 (2003).
  PubMed Google Scholar
• Roux, F. & Couraud, P. O. Rat brain endothelial cell lines for the study of blood–brain barrier permeability and transport functions. Cell Mol. Neurobiol. 25, 41–58 (2005).
  PubMed Google Scholar
• Förster, C. et al. Occludin as direct target for glucocorticoid-induced improvement of blood–brain barrier properties in a murine in vitro system. J. Physiol. 565, 475–486 (2005).
  PubMed PubMed Central Google Scholar
• Scism, J. L. et al. Evaluation of an in vitro coculture model for the blood–brain barrier: Comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources. In Vitro Cell Dev. Biol. Anim. 35, 580–592 (1999).
  CAS PubMed Google Scholar
• Dejana, E. Endothelial cell–cell junctions: happy together. Nature Rev. Mol. Cell Biol. 5, 261–270, (2004).
  CAS Google Scholar
• Vorbrodt, A. W. & Dobrogowska, D. H. Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view. Brain Res. Brain Res. Rev. 42, 221–242 (2003).
  CAS PubMed Google Scholar
• Lundquist, S. et al. Prediction of drug transport through the blood–brain barrier in vivo: a comparison between two in vitro cell models. Pharm. Res. 19, 976–981 (2002).
  CAS PubMed Google Scholar
• Franzén, B. et al. Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-α. Mol. Brain Res. 115, 130–146 (2003). References 90–96 demonstrate efforts in identifying genes and proteins at the brain endothelium that could be potential therapeutic targets and highlight differences between peripheral and brain endothelium.
  PubMed Google Scholar
• Shusta, E. V., Boado, R. J., Mathern, G. W. & Pardridge, W. M. Vascular genomics of the human brain. J. Cereb. Blood Flow Metab. 22, 245–252 (2002).
  CAS PubMed Google Scholar
• Li, J. Y., Boado, R. J. & Pardridge, W. M. Blood–brain barrier genomics. J. Cereb. Blood Flow Metab. 21, 61–68 (2001).
  CAS PubMed Google Scholar
• Li, J. Y., Boado, R. J. & Pardridge, W. M. Rat blood–brain barrier genomics. II. J. Cereb. Blood Flow Metab. 22, 1319–1326 (2002).
  CAS PubMed Google Scholar
• Shusta, E. V., Boado, R. J. & Pardridge, W. M. Vascular proteomics and subtractive antibody expression cloning. Mol. Cell. Proteomics 1, 75–82 (2002).
  CAS PubMed Google Scholar
• Shusta, E. V., Zhu, C., Boado, R. J. & Pardridge, W. M. Subtractive expression cloning reveals high expression of CD46 at the blood–brain barrier. J. Neuropathol. Exp. Neurol. 61, 597–604 (2002).
  CAS PubMed Google Scholar
• Shusta, E. V., Li J. Y., Boado, R. J. & Pardridge, W. M. The Ro52/SS-A autoantigen has elevated expression at the brain microvasculature. Neuroreport 14, 1861–1865 (2003).
  CAS PubMed Google Scholar
• Stanness, K. A. et al. Morphological and functional characterisation of an in vitro blood–brain barrier model. Brain Res. 771, 329–342 (1997).
  CAS PubMed Google Scholar
• Cucullo, L., et al. Development of a humanized in vitro blood–brain barrier model to screen for brain penetration of antiepileptic drugs. Epilepsia 48, 505–516 (2007).
  CAS PubMed Google Scholar
• Leybaert, L. Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling? J. Cereb. Blood Flow Metab. 25, 2–16 (2005).
  CAS PubMed Google Scholar
• Berezowski, V. et al. Transport screening of drug cocktails through an in vitro blood–brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline? Pharm Res. 21, 756–760 (2004).
  CAS PubMed Google Scholar
• Dehouck, B. et al. A new function for the LDL receptor: transcytosis of LDL across the blood–brain barrier. J. Cell Biol. 138, 877–889 (1997). One of the first papers describing trancytosis of LDL across the BBB in vitro.
  CAS PubMed PubMed Central Google Scholar
• Cipolla, M. J., Crete, R., Vitullo, L. & Rix, R. D. Transcellular transport as a mechanism of blood–brain barrier disruption during stroke. Front. Biosci. 9, 777–785 (2004).
  CAS PubMed Google Scholar
• Kaur, C., Sivakumar, V., Zhang, Y. & Ling, E. A. Hypoxia-induced astrocytic reaction and increased vascular permeability in the rat cerebellum. Glia 54, 826–839 (2006).
  CAS PubMed Google Scholar
• Spencer, B. J. & Verma, I. M. Targeted delivery of proteins across the blood–brain barrier. Proc. Natl Acad. Sci. USA 104, 7594–7599 (2007).
  CAS PubMed Google Scholar
• Enerson, B. E. & Drewes, L. R. The rat blood–brain barrier transcriptome. J. Cereb. Blood Flow Metab. 26, 959–973 (2006).
  CAS PubMed Google Scholar
• Fiala, M. et al. Amyloid-β induces chemokine secretion and monocyte migration across a human blood–brain barrier. Mol. Med. 4, 480–489 (1998).
  CAS PubMed PubMed Central Google Scholar
• Giri, R. et al. β-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 279, C1772–C1781 (2000).
  CAS PubMed Google Scholar
• Poduslo, J. F., Curran, G. L., Wengenack, T. M., Malester, B. & Duff, K. Permeability of proteins at the blood–brain barrier in the normal adult mouse and the double transgenic mouse model of Alzheimer´s disease. Neurobiol. Dis. 8, 555–567 (2001).
  CAS PubMed Google Scholar
• Ujiie, M., Dickstein, D. L., Carlow, D. A. & Jefferies, W. A. Blood–brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10, 463–470 (2003).
  CAS PubMed Google Scholar
• Iadecola, C. Atherosclerosis and neurodegeneration: unexpected conspirators in Alzheimer's dementia. Arterioscler. Thromb. Vasc. Biol. 23, 1951–1953 (2003).
  CAS PubMed Google Scholar
• Thomas, T., Thomas, G., McLendon, C., Sutton, T. & Mullan, M. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168–171 (1996). An important paper linking Aβ to vascular reactivity by free radicals.
  CAS PubMed Google Scholar
• Paris, D. et al. Vasoactive effects of Aβ in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation. Neurol. Res. 25, 642–651 (2003).
  CAS PubMed Google Scholar
• Iadecola, C. et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nature Neurosci. 2, 157–161 (1999). An interesting paper showing that vascular oxidative stress alters endothelium-dependent cerebral blood-flow responses in mice overexpressing amyloid precursor protein.
  CAS PubMed Google Scholar
• DeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M. & Holtzman, D. M. Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264–2267 (2002). References 111–114 demonstrate transport of Aβ across the blood–brain barrier from blood-to-brain and from brain-to-blood indicating the importance of kinetic and dynamic considerations in the study of Aβ accumulation in brain.
  CAS PubMed Google Scholar
• Minagar, A. & Alexander, J. S. Blood–brain barrier disruption in multiple sclerosis. Mult. Scler. 9, 540–549 (2003).
  CAS PubMed Google Scholar
• Veldhuis, W. B. et al. Interferon-β prevents cytokine-induced neutrophil infiltration and attenuates blood–brain barrier disruption. J. Cereb. Blood Flow Metab. 23, 1060–1069 (2003).
  CAS PubMed Google Scholar
• Dallasta, L. M. et al. Blood–brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155, 1915–1927 (1999).
  CAS PubMed PubMed Central Google Scholar
• Davies, D. C. Blood–brain barrier breakdown in septic encephalopathy and brain tumors. J. Anat. 200, 639–646 (2002).
  CAS PubMed PubMed Central Google Scholar
• Lo, E. H., Dalkara, T. & Moskowitz, M. A. Mechanisms, challenges and opportunities in stroke. Nature Rev. Neurosci. 4, 399–415 (2003).
  CAS Google Scholar
• Gasche, Y. et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischaemia in mice: a possible role in blood–brain barrier dysfuntion. J. Cereb. Blood Flow Metab. 19, 1020–1028 (1999).
  CAS PubMed Google Scholar
• Huber, J. D. et al. Inflammatory pain alters blood–brain barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart Circ. Physiol. 280, H1241–H1248 (2001).
  CAS PubMed Google Scholar
• Weidenfeller, C., Svendsen, C. N., Shusta, E. V. Differentiating embryonic neural progenitor cells induce blood–brain barrier properties. J. Neurochem. 101, 555–565 (2007).
  CAS PubMed PubMed Central Google Scholar
• Zhang, Z. G., Zhang, L., Jiang, Q. & Chopp, M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischaemia in the adult mouse. Circ. Res. 90, 284–288 (2002).
  CAS PubMed Google Scholar